Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Fusion | 66 | 2024 | 1275 | 10.340 |
Why?
|
Spinal Neoplasms | 34 | 2024 | 703 | 9.330 |
Why?
|
Military Personnel | 53 | 2024 | 1245 | 8.890 |
Why?
|
Spinal Injuries | 25 | 2023 | 300 | 6.070 |
Why?
|
Spine | 35 | 2024 | 1112 | 5.820 |
Why?
|
Epidural Abscess | 10 | 2024 | 94 | 5.750 |
Why?
|
Spinal Fractures | 26 | 2024 | 704 | 5.480 |
Why?
|
Lumbar Vertebrae | 51 | 2024 | 1874 | 5.360 |
Why?
|
Spinal Diseases | 18 | 2024 | 561 | 5.200 |
Why?
|
Orthopedic Procedures | 22 | 2021 | 1265 | 4.520 |
Why?
|
Cervical Vertebrae | 32 | 2024 | 976 | 4.500 |
Why?
|
Postoperative Complications | 84 | 2024 | 15609 | 4.420 |
Why?
|
Orthopedics | 25 | 2024 | 898 | 4.280 |
Why?
|
Lordosis | 18 | 2024 | 92 | 4.150 |
Why?
|
Diskectomy | 15 | 2023 | 208 | 3.910 |
Why?
|
Kyphosis | 17 | 2023 | 237 | 3.510 |
Why?
|
Scoliosis | 15 | 2024 | 740 | 3.150 |
Why?
|
Afghan Campaign 2001- | 19 | 2021 | 298 | 3.130 |
Why?
|
Blast Injuries | 10 | 2022 | 322 | 2.640 |
Why?
|
Healthcare Disparities | 20 | 2024 | 3351 | 2.630 |
Why?
|
Opioid-Related Disorders | 14 | 2024 | 2164 | 2.580 |
Why?
|
Analgesics, Opioid | 24 | 2024 | 3805 | 2.430 |
Why?
|
Pain, Postoperative | 14 | 2023 | 1737 | 2.380 |
Why?
|
Arthroplasty, Replacement, Knee | 13 | 2024 | 1393 | 2.340 |
Why?
|
Military Medicine | 13 | 2016 | 184 | 2.330 |
Why?
|
Retrospective Studies | 180 | 2024 | 80583 | 2.190 |
Why?
|
Arthroplasty, Replacement, Hip | 13 | 2024 | 1413 | 2.110 |
Why?
|
Surgical Procedures, Operative | 15 | 2024 | 1924 | 2.100 |
Why?
|
Patient Readmission | 21 | 2024 | 3269 | 2.030 |
Why?
|
Neurosurgical Procedures | 20 | 2022 | 2067 | 1.880 |
Why?
|
Medicare | 27 | 2024 | 6774 | 1.750 |
Why?
|
Spinal Stenosis | 7 | 2022 | 261 | 1.730 |
Why?
|
Musculoskeletal System | 7 | 2019 | 188 | 1.720 |
Why?
|
Humans | 412 | 2024 | 760740 | 1.690 |
Why?
|
Wounds, Gunshot | 9 | 2020 | 582 | 1.540 |
Why?
|
Thoracic Vertebrae | 12 | 2024 | 597 | 1.470 |
Why?
|
Male | 224 | 2024 | 360402 | 1.460 |
Why?
|
Hip Fractures | 7 | 2024 | 988 | 1.450 |
Why?
|
Periodicals as Topic | 11 | 2024 | 1463 | 1.440 |
Why?
|
Adult | 185 | 2024 | 220995 | 1.440 |
Why?
|
United States | 108 | 2024 | 72292 | 1.420 |
Why?
|
Wounds and Injuries | 14 | 2019 | 2492 | 1.410 |
Why?
|
Hospitals, Military | 5 | 2021 | 62 | 1.410 |
Why?
|
Female | 233 | 2024 | 392203 | 1.410 |
Why?
|
Wounds, Nonpenetrating | 7 | 2023 | 806 | 1.370 |
Why?
|
Middle Aged | 161 | 2024 | 220603 | 1.370 |
Why?
|
Odontoid Process | 3 | 2024 | 46 | 1.360 |
Why?
|
Quality of Life | 27 | 2024 | 13359 | 1.340 |
Why?
|
Spondylosis | 5 | 2022 | 84 | 1.330 |
Why?
|
Health Expenditures | 11 | 2023 | 2363 | 1.320 |
Why?
|
Leadership | 3 | 2023 | 1385 | 1.250 |
Why?
|
Decompression, Surgical | 11 | 2022 | 606 | 1.230 |
Why?
|
Aged | 124 | 2024 | 169092 | 1.140 |
Why?
|
Radiculopathy | 3 | 2016 | 201 | 1.140 |
Why?
|
Spinal Cord Injuries | 10 | 2014 | 924 | 1.130 |
Why?
|
Efficiency | 4 | 2023 | 476 | 1.110 |
Why?
|
Fractures, Compression | 3 | 2022 | 131 | 1.100 |
Why?
|
Length of Stay | 14 | 2024 | 6418 | 1.080 |
Why?
|
Spinal Cord Compression | 4 | 2024 | 233 | 1.040 |
Why?
|
Health Care Costs | 12 | 2023 | 3238 | 1.040 |
Why?
|
Injury Severity Score | 9 | 2021 | 1045 | 1.030 |
Why?
|
Lumbosacral Region | 6 | 2021 | 293 | 0.970 |
Why?
|
Health Services Accessibility | 8 | 2023 | 5430 | 0.960 |
Why?
|
Spondylolisthesis | 4 | 2024 | 172 | 0.960 |
Why?
|
PubMed | 2 | 2015 | 129 | 0.950 |
Why?
|
Drug Prescriptions | 5 | 2024 | 1669 | 0.940 |
Why?
|
Incidence | 37 | 2024 | 21339 | 0.940 |
Why?
|
Hospital Mortality | 14 | 2024 | 5292 | 0.930 |
Why?
|
Treatment Outcome | 68 | 2024 | 64572 | 0.920 |
Why?
|
Benchmarking | 4 | 2023 | 1045 | 0.900 |
Why?
|
Low Back Pain | 7 | 2024 | 982 | 0.890 |
Why?
|
Sciatica | 2 | 2023 | 97 | 0.860 |
Why?
|
Arthroplasty, Replacement | 3 | 2018 | 309 | 0.860 |
Why?
|
Bone Screws | 6 | 2009 | 530 | 0.850 |
Why?
|
Minority Groups | 2 | 2021 | 1202 | 0.830 |
Why?
|
Aged, 80 and over | 48 | 2024 | 58919 | 0.820 |
Why?
|
Telemedicine | 8 | 2023 | 3051 | 0.810 |
Why?
|
Risk Factors | 52 | 2024 | 74128 | 0.800 |
Why?
|
Femoral Neck Fractures | 3 | 2015 | 142 | 0.800 |
Why?
|
Faculty | 2 | 2015 | 383 | 0.780 |
Why?
|
Lung Neoplasms | 10 | 2022 | 13383 | 0.780 |
Why?
|
Delivery of Health Care | 9 | 2024 | 5334 | 0.780 |
Why?
|
Bariatric Surgery | 2 | 2022 | 992 | 0.760 |
Why?
|
Logistic Models | 17 | 2019 | 13248 | 0.760 |
Why?
|
Ecosystem | 2 | 2022 | 487 | 0.750 |
Why?
|
Neck Injuries | 2 | 2019 | 160 | 0.730 |
Why?
|
Osteotomy | 6 | 2024 | 836 | 0.720 |
Why?
|
Obesity, Morbid | 2 | 2022 | 1276 | 0.720 |
Why?
|
Insurance, Health | 6 | 2020 | 2495 | 0.720 |
Why?
|
Surgical Wound Infection | 2 | 2020 | 1529 | 0.700 |
Why?
|
Arthrodesis | 3 | 2019 | 186 | 0.690 |
Why?
|
Musculoskeletal Diseases | 3 | 2022 | 597 | 0.680 |
Why?
|
Independent Living | 1 | 2024 | 577 | 0.680 |
Why?
|
Dementia | 2 | 2024 | 2686 | 0.660 |
Why?
|
Young Adult | 48 | 2024 | 59191 | 0.650 |
Why?
|
Patient Acceptance of Health Care | 7 | 2022 | 3196 | 0.650 |
Why?
|
Multiple Trauma | 3 | 2017 | 369 | 0.640 |
Why?
|
Emergency Treatment | 2 | 2019 | 495 | 0.640 |
Why?
|
Cohort Studies | 24 | 2024 | 41464 | 0.630 |
Why?
|
Quality of Health Care | 6 | 2023 | 4325 | 0.620 |
Why?
|
Cefazolin | 1 | 2019 | 94 | 0.620 |
Why?
|
Neurosurgery | 2 | 2015 | 679 | 0.620 |
Why?
|
Dura Mater | 1 | 2020 | 290 | 0.620 |
Why?
|
Arthritis | 1 | 2024 | 680 | 0.610 |
Why?
|
Biomedical Research | 12 | 2024 | 3426 | 0.610 |
Why?
|
Socioeconomic Factors | 7 | 2024 | 7805 | 0.600 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 231 | 0.590 |
Why?
|
Shear Strength | 2 | 2008 | 160 | 0.590 |
Why?
|
Bibliometrics | 1 | 2021 | 352 | 0.590 |
Why?
|
Disability Evaluation | 9 | 2024 | 1835 | 0.570 |
Why?
|
Ambulatory Care | 2 | 2018 | 2768 | 0.570 |
Why?
|
Fellowships and Scholarships | 3 | 2023 | 1116 | 0.570 |
Why?
|
Fracture Fixation | 1 | 2019 | 366 | 0.560 |
Why?
|
Sex Factors | 17 | 2024 | 10549 | 0.550 |
Why?
|
Health Care Reform | 3 | 2019 | 1247 | 0.550 |
Why?
|
Medical Records Systems, Computerized | 1 | 2022 | 1191 | 0.540 |
Why?
|
Reoperation | 14 | 2024 | 4300 | 0.540 |
Why?
|
Mobility Limitation | 1 | 2020 | 408 | 0.530 |
Why?
|
Patient Discharge | 7 | 2023 | 3442 | 0.530 |
Why?
|
Osteomyelitis | 1 | 2020 | 407 | 0.530 |
Why?
|
Fee-for-Service Plans | 2 | 2019 | 697 | 0.520 |
Why?
|
Chondrosarcoma | 2 | 2024 | 295 | 0.520 |
Why?
|
Walking | 3 | 2022 | 1197 | 0.520 |
Why?
|
United States Department of Defense | 4 | 2020 | 34 | 0.520 |
Why?
|
Menisci, Tibial | 2 | 2009 | 267 | 0.510 |
Why?
|
Vancomycin | 1 | 2019 | 503 | 0.510 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 141 | 0.500 |
Why?
|
Salaries and Fringe Benefits | 1 | 2017 | 256 | 0.500 |
Why?
|
Quality Indicators, Health Care | 3 | 2023 | 1790 | 0.500 |
Why?
|
Coronary Artery Bypass | 5 | 2023 | 2188 | 0.500 |
Why?
|
Amputation, Traumatic | 2 | 2013 | 135 | 0.500 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2022 | 5319 | 0.490 |
Why?
|
Heart Arrest | 2 | 2015 | 1513 | 0.490 |
Why?
|
Postoperative Period | 7 | 2020 | 1812 | 0.490 |
Why?
|
Prescriptions | 6 | 2023 | 386 | 0.490 |
Why?
|
Hyperglycemia | 2 | 2020 | 1375 | 0.480 |
Why?
|
Chordoma | 2 | 2015 | 347 | 0.480 |
Why?
|
Emergency Service, Hospital | 8 | 2021 | 7873 | 0.470 |
Why?
|
Recovery of Function | 6 | 2015 | 2977 | 0.470 |
Why?
|
Prognosis | 19 | 2024 | 29601 | 0.460 |
Why?
|
Afghanistan | 4 | 2016 | 77 | 0.460 |
Why?
|
Knee Prosthesis | 1 | 2017 | 395 | 0.450 |
Why?
|
Adolescent | 40 | 2024 | 88247 | 0.450 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12043 | 0.450 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 637 | 0.440 |
Why?
|
Workload | 1 | 2019 | 844 | 0.440 |
Why?
|
Age Distribution | 8 | 2014 | 2872 | 0.430 |
Why?
|
Tomography, X-Ray Computed | 15 | 2024 | 20556 | 0.430 |
Why?
|
Orthotic Devices | 2 | 2011 | 129 | 0.430 |
Why?
|
Platelet Count | 4 | 2020 | 780 | 0.420 |
Why?
|
Withholding Treatment | 1 | 2017 | 615 | 0.420 |
Why?
|
Hyperostosis, Diffuse Idiopathic Skeletal | 2 | 2019 | 23 | 0.410 |
Why?
|
Databases, Factual | 13 | 2021 | 7963 | 0.410 |
Why?
|
Traumatology | 2 | 2019 | 100 | 0.410 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 368 | 0.410 |
Why?
|
Prostheses and Implants | 2 | 2011 | 1269 | 0.410 |
Why?
|
Prospective Studies | 23 | 2024 | 54364 | 0.410 |
Why?
|
Organizational Policy | 1 | 2015 | 432 | 0.410 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 825 | 0.410 |
Why?
|
Polyradiculopathy | 1 | 2012 | 23 | 0.400 |
Why?
|
Fractures, Bone | 3 | 2013 | 2045 | 0.400 |
Why?
|
Mentors | 1 | 2018 | 661 | 0.400 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 934 | 0.400 |
Why?
|
Patients | 3 | 2023 | 906 | 0.400 |
Why?
|
Age Factors | 11 | 2020 | 18381 | 0.390 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4845 | 0.390 |
Why?
|
Risk Adjustment | 1 | 2015 | 600 | 0.390 |
Why?
|
Germany | 3 | 2023 | 872 | 0.390 |
Why?
|
Program Evaluation | 2 | 2019 | 2486 | 0.390 |
Why?
|
Bone Neoplasms | 3 | 2015 | 2527 | 0.390 |
Why?
|
Movement Disorders | 1 | 2015 | 459 | 0.380 |
Why?
|
Survival Analysis | 10 | 2020 | 10072 | 0.380 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2015 | 602 | 0.380 |
Why?
|
Comorbidity | 11 | 2019 | 10507 | 0.380 |
Why?
|
Skilled Nursing Facilities | 1 | 2016 | 399 | 0.380 |
Why?
|
Soft Tissue Injuries | 1 | 2013 | 172 | 0.380 |
Why?
|
Health Resources | 1 | 2017 | 934 | 0.380 |
Why?
|
Carcinoma | 2 | 2019 | 2328 | 0.380 |
Why?
|
Endoscopy | 1 | 2021 | 1851 | 0.370 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1406 | 0.370 |
Why?
|
Pelvic Bones | 1 | 2013 | 270 | 0.370 |
Why?
|
Wound Infection | 1 | 2013 | 244 | 0.370 |
Why?
|
Drug Utilization | 1 | 2017 | 1186 | 0.370 |
Why?
|
Combat Disorders | 1 | 2013 | 301 | 0.370 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1380 | 0.370 |
Why?
|
England | 3 | 2022 | 526 | 0.370 |
Why?
|
Spondylitis, Ankylosing | 2 | 2019 | 155 | 0.370 |
Why?
|
Registries | 12 | 2017 | 8209 | 0.370 |
Why?
|
Osteoporosis | 5 | 2022 | 1604 | 0.370 |
Why?
|
Bone Transplantation | 2 | 2024 | 927 | 0.360 |
Why?
|
Femoral Fractures | 3 | 2012 | 375 | 0.360 |
Why?
|
Brain Concussion | 1 | 2022 | 1403 | 0.360 |
Why?
|
Resuscitation | 1 | 2015 | 672 | 0.360 |
Why?
|
Risk Assessment | 13 | 2024 | 23974 | 0.360 |
Why?
|
Fibrous Dysplasia, Monostotic | 1 | 2010 | 8 | 0.360 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3820 | 0.350 |
Why?
|
Bone Substitutes | 3 | 2008 | 236 | 0.350 |
Why?
|
Pain | 11 | 2023 | 5062 | 0.340 |
Why?
|
Postoperative Care | 1 | 2016 | 1467 | 0.340 |
Why?
|
Kaplan-Meier Estimate | 5 | 2023 | 6473 | 0.340 |
Why?
|
Talus | 2 | 2010 | 86 | 0.340 |
Why?
|
Health Services Research | 3 | 2024 | 1808 | 0.340 |
Why?
|
Quality Improvement | 9 | 2022 | 3801 | 0.340 |
Why?
|
Pandemics | 10 | 2024 | 8652 | 0.340 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5838 | 0.330 |
Why?
|
Patient Care Team | 1 | 2021 | 2515 | 0.330 |
Why?
|
Spinal Curvatures | 6 | 2024 | 71 | 0.330 |
Why?
|
Acetabulum | 1 | 2013 | 542 | 0.330 |
Why?
|
Materials Testing | 4 | 2009 | 863 | 0.320 |
Why?
|
Time Factors | 16 | 2020 | 39908 | 0.320 |
Why?
|
Emergency Medical Services | 3 | 2022 | 1921 | 0.310 |
Why?
|
Continuity of Patient Care | 1 | 2016 | 1067 | 0.310 |
Why?
|
Delirium | 1 | 2020 | 1667 | 0.310 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4910 | 0.300 |
Why?
|
Tissue Engineering | 2 | 2009 | 1865 | 0.300 |
Why?
|
History, 19th Century | 4 | 2011 | 718 | 0.300 |
Why?
|
Odds Ratio | 6 | 2022 | 9644 | 0.300 |
Why?
|
Sex Distribution | 5 | 2013 | 2278 | 0.300 |
Why?
|
Research Design | 3 | 2021 | 6174 | 0.290 |
Why?
|
Cost Savings | 4 | 2023 | 912 | 0.290 |
Why?
|
Cost-Benefit Analysis | 4 | 2024 | 5493 | 0.290 |
Why?
|
Back Pain | 3 | 2022 | 545 | 0.290 |
Why?
|
Liver Diseases | 1 | 2016 | 1297 | 0.290 |
Why?
|
Natural Language Processing | 3 | 2022 | 1166 | 0.290 |
Why?
|
Massachusetts | 7 | 2024 | 8835 | 0.290 |
Why?
|
Lymphocyte Count | 2 | 2019 | 777 | 0.280 |
Why?
|
Follow-Up Studies | 17 | 2024 | 39062 | 0.280 |
Why?
|
Hepatitis C | 1 | 2017 | 1580 | 0.280 |
Why?
|
Myocardial Infarction | 3 | 2022 | 11458 | 0.280 |
Why?
|
History, 18th Century | 3 | 2011 | 206 | 0.280 |
Why?
|
Congresses as Topic | 1 | 2012 | 802 | 0.270 |
Why?
|
Hospitals, Teaching | 1 | 2011 | 1155 | 0.270 |
Why?
|
Famous Persons | 1 | 2008 | 109 | 0.270 |
Why?
|
Developed Countries | 4 | 2021 | 450 | 0.270 |
Why?
|
Vertebroplasty | 1 | 2007 | 78 | 0.270 |
Why?
|
Florida | 2 | 2017 | 429 | 0.270 |
Why?
|
Iraq | 3 | 2016 | 92 | 0.270 |
Why?
|
Leg | 1 | 2011 | 1087 | 0.260 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2007 | 118 | 0.260 |
Why?
|
Shoulder Dislocation | 1 | 2007 | 129 | 0.250 |
Why?
|
Tissue Scaffolds | 2 | 2010 | 932 | 0.250 |
Why?
|
Pain Measurement | 8 | 2022 | 3546 | 0.250 |
Why?
|
Health Policy | 2 | 2014 | 2682 | 0.250 |
Why?
|
History, 21st Century | 4 | 2012 | 1566 | 0.250 |
Why?
|
Venous Thrombosis | 2 | 2019 | 1303 | 0.250 |
Why?
|
Guidelines as Topic | 2 | 2024 | 1386 | 0.240 |
Why?
|
Schools, Medical | 1 | 2011 | 878 | 0.240 |
Why?
|
Hospitals | 3 | 2024 | 3879 | 0.240 |
Why?
|
Venous Thromboembolism | 2 | 2019 | 1866 | 0.240 |
Why?
|
Fracture Fixation, Internal | 2 | 2008 | 971 | 0.240 |
Why?
|
Fractures, Ununited | 1 | 2006 | 175 | 0.240 |
Why?
|
Osteosarcoma | 1 | 2010 | 896 | 0.230 |
Why?
|
Publishing | 1 | 2012 | 832 | 0.230 |
Why?
|
Propensity Score | 4 | 2023 | 1912 | 0.230 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1878 | 0.230 |
Why?
|
North America | 5 | 2021 | 1273 | 0.220 |
Why?
|
Morbidity | 4 | 2020 | 1750 | 0.220 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15829 | 0.220 |
Why?
|
Rotator Cuff | 1 | 2007 | 348 | 0.220 |
Why?
|
Survival Rate | 7 | 2019 | 12719 | 0.220 |
Why?
|
Tramadol | 1 | 2024 | 60 | 0.220 |
Why?
|
Mortality | 3 | 2020 | 2899 | 0.220 |
Why?
|
Health Status Disparities | 1 | 2015 | 1846 | 0.220 |
Why?
|
Chondrocytes | 1 | 2009 | 792 | 0.220 |
Why?
|
Public-Private Sector Partnerships | 1 | 2024 | 123 | 0.220 |
Why?
|
Referral and Consultation | 2 | 2016 | 3599 | 0.220 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4575 | 0.220 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3680 | 0.210 |
Why?
|
Quality-Adjusted Life Years | 3 | 2024 | 1723 | 0.210 |
Why?
|
Editorial Policies | 2 | 2024 | 458 | 0.210 |
Why?
|
Magnetic Resonance Imaging | 8 | 2021 | 36401 | 0.210 |
Why?
|
Language | 2 | 2023 | 1541 | 0.210 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1400 | 0.200 |
Why?
|
Probability | 2 | 2023 | 2475 | 0.200 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3410 | 0.200 |
Why?
|
Radiography | 7 | 2016 | 6961 | 0.190 |
Why?
|
Internship and Residency | 5 | 2023 | 5878 | 0.190 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26065 | 0.190 |
Why?
|
Poisson Distribution | 2 | 2013 | 504 | 0.190 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2022 | 100 | 0.190 |
Why?
|
Osteoarthritis | 2 | 2023 | 1063 | 0.190 |
Why?
|
Violence | 1 | 2008 | 936 | 0.190 |
Why?
|
Neck | 2 | 2023 | 734 | 0.190 |
Why?
|
Pelvis | 4 | 2024 | 732 | 0.190 |
Why?
|
Cross-Cultural Comparison | 2 | 2021 | 634 | 0.190 |
Why?
|
Pulmonary Embolism | 2 | 2019 | 2568 | 0.190 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2021 | 1187 | 0.190 |
Why?
|
Trauma Severity Indices | 3 | 2013 | 478 | 0.190 |
Why?
|
Bone Plates | 3 | 2022 | 464 | 0.180 |
Why?
|
Preoperative Care | 2 | 2021 | 2242 | 0.180 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20988 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3683 | 0.180 |
Why?
|
Morphine Derivatives | 1 | 2020 | 42 | 0.180 |
Why?
|
Inpatients | 4 | 2021 | 2545 | 0.180 |
Why?
|
Insurance | 1 | 2022 | 113 | 0.180 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2020 | 37 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7403 | 0.180 |
Why?
|
Laminectomy | 3 | 2021 | 225 | 0.180 |
Why?
|
Case-Control Studies | 6 | 2023 | 22153 | 0.180 |
Why?
|
Decision Making | 3 | 2020 | 3919 | 0.180 |
Why?
|
Interviews as Topic | 3 | 2024 | 2697 | 0.170 |
Why?
|
Atlanto-Axial Joint | 2 | 2011 | 60 | 0.170 |
Why?
|
Diskectomy, Percutaneous | 1 | 2019 | 14 | 0.170 |
Why?
|
Pneumonia | 2 | 2023 | 2143 | 0.170 |
Why?
|
Qualitative Research | 2 | 2021 | 3017 | 0.170 |
Why?
|
Bayes Theorem | 2 | 2020 | 2327 | 0.170 |
Why?
|
Arthroscopy | 3 | 2012 | 969 | 0.170 |
Why?
|
Albumins | 1 | 2022 | 575 | 0.160 |
Why?
|
Lymphoma | 2 | 2019 | 1899 | 0.160 |
Why?
|
Extremities | 2 | 2016 | 867 | 0.160 |
Why?
|
Biocompatible Materials | 1 | 2007 | 1683 | 0.160 |
Why?
|
Equipment Failure Analysis | 4 | 2012 | 843 | 0.160 |
Why?
|
Reference Standards | 1 | 2023 | 1003 | 0.160 |
Why?
|
Bone Nails | 2 | 2012 | 220 | 0.160 |
Why?
|
Frail Elderly | 2 | 2021 | 765 | 0.160 |
Why?
|
History, 20th Century | 3 | 2011 | 2764 | 0.160 |
Why?
|
Stress, Mechanical | 6 | 2011 | 1674 | 0.160 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15250 | 0.160 |
Why?
|
Zygapophyseal Joint | 1 | 2021 | 127 | 0.160 |
Why?
|
Spinal Cord Diseases | 1 | 2021 | 291 | 0.160 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 285 | 0.160 |
Why?
|
Membrane Proteins | 1 | 2015 | 7847 | 0.160 |
Why?
|
Treatment Failure | 2 | 2019 | 2635 | 0.160 |
Why?
|
Sarcopenia | 1 | 2023 | 370 | 0.160 |
Why?
|
Fracture Fixation, Intramedullary | 2 | 2012 | 159 | 0.150 |
Why?
|
Health Plan Implementation | 1 | 2021 | 335 | 0.150 |
Why?
|
Databases as Topic | 1 | 2020 | 473 | 0.150 |
Why?
|
Goals | 1 | 2023 | 708 | 0.150 |
Why?
|
Kyphoplasty | 1 | 2018 | 44 | 0.150 |
Why?
|
Australia | 4 | 2021 | 1249 | 0.150 |
Why?
|
Cumulative Trauma Disorders | 1 | 1999 | 151 | 0.150 |
Why?
|
Medicaid | 3 | 2021 | 2814 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2019 | 267 | 0.140 |
Why?
|
Acrylamides | 1 | 2019 | 259 | 0.140 |
Why?
|
Knee Injuries | 2 | 2012 | 488 | 0.140 |
Why?
|
Stroke | 2 | 2018 | 9715 | 0.140 |
Why?
|
Chemoprevention | 1 | 2019 | 325 | 0.140 |
Why?
|
Physicians | 3 | 2011 | 4583 | 0.140 |
Why?
|
Reimbursement, Incentive | 1 | 2022 | 542 | 0.140 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13635 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 212 | 0.140 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12448 | 0.130 |
Why?
|
Bone Marrow Neoplasms | 1 | 1997 | 101 | 0.130 |
Why?
|
California | 2 | 2017 | 1431 | 0.130 |
Why?
|
Health Benefit Plans, Employee | 1 | 2019 | 332 | 0.130 |
Why?
|
Specialties, Surgical | 1 | 2021 | 390 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2020 | 1597 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1663 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15908 | 0.130 |
Why?
|
Hospitalization | 7 | 2024 | 10708 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 414 | 0.130 |
Why?
|
Carpal Tunnel Syndrome | 1 | 1999 | 303 | 0.130 |
Why?
|
International Classification of Diseases | 2 | 2012 | 912 | 0.130 |
Why?
|
Keratins | 1 | 1997 | 498 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2024 | 20077 | 0.130 |
Why?
|
Blood Glucose | 2 | 2020 | 6390 | 0.130 |
Why?
|
Education, Medical, Graduate | 3 | 2012 | 2373 | 0.130 |
Why?
|
Heart Diseases | 2 | 2022 | 2778 | 0.120 |
Why?
|
Tourniquets | 1 | 2016 | 107 | 0.120 |
Why?
|
Spinal Cord | 2 | 2015 | 1807 | 0.120 |
Why?
|
Models, Biological | 2 | 2008 | 9461 | 0.120 |
Why?
|
Journal Impact Factor | 1 | 2016 | 153 | 0.120 |
Why?
|
Focus Groups | 1 | 2021 | 1409 | 0.120 |
Why?
|
Social Class | 2 | 2022 | 1993 | 0.120 |
Why?
|
Professional Role | 1 | 2018 | 313 | 0.120 |
Why?
|
Uterine Cervical Incompetence | 1 | 1994 | 24 | 0.120 |
Why?
|
Delphi Technique | 3 | 2023 | 846 | 0.120 |
Why?
|
Insurance Coverage | 3 | 2021 | 1937 | 0.120 |
Why?
|
Europe | 4 | 2021 | 3415 | 0.120 |
Why?
|
Blood Loss, Surgical | 2 | 2015 | 636 | 0.120 |
Why?
|
Blood Transfusion, Autologous | 1 | 2015 | 130 | 0.120 |
Why?
|
Creatinine | 1 | 2020 | 1895 | 0.120 |
Why?
|
Mental Disorders | 1 | 2014 | 6826 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14599 | 0.120 |
Why?
|
Heart Failure | 4 | 2022 | 11670 | 0.120 |
Why?
|
Cesarean Section | 4 | 2022 | 1396 | 0.110 |
Why?
|
Bone Density | 2 | 2024 | 3548 | 0.110 |
Why?
|
Managed Care Programs | 1 | 2019 | 937 | 0.110 |
Why?
|
Obesity | 6 | 2023 | 12934 | 0.110 |
Why?
|
Reimbursement Mechanisms | 1 | 2019 | 667 | 0.110 |
Why?
|
Anterior Compartment Syndrome | 1 | 2013 | 8 | 0.110 |
Why?
|
Shock, Traumatic | 1 | 2013 | 22 | 0.110 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7390 | 0.110 |
Why?
|
Aniline Compounds | 1 | 2019 | 1068 | 0.110 |
Why?
|
Polytetrafluoroethylene | 1 | 1994 | 245 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1241 | 0.110 |
Why?
|
Prosthesis Failure | 2 | 2017 | 1204 | 0.110 |
Why?
|
Models, Economic | 1 | 2017 | 714 | 0.110 |
Why?
|
Osteoporotic Fractures | 1 | 2018 | 410 | 0.110 |
Why?
|
Income | 2 | 2019 | 1870 | 0.110 |
Why?
|
Motivation | 1 | 2023 | 2003 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2924 | 0.110 |
Why?
|
Physical Examination | 1 | 2019 | 1254 | 0.110 |
Why?
|
Trauma, Nervous System | 1 | 2013 | 35 | 0.110 |
Why?
|
Faculty, Medical | 1 | 2021 | 1204 | 0.110 |
Why?
|
Patient Preference | 1 | 2021 | 925 | 0.110 |
Why?
|
Drug Costs | 1 | 2021 | 1183 | 0.110 |
Why?
|
Equipment Design | 4 | 2008 | 3501 | 0.110 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1419 | 0.100 |
Why?
|
Polyesters | 1 | 1994 | 371 | 0.100 |
Why?
|
Bone Cysts | 2 | 2010 | 48 | 0.100 |
Why?
|
Serum Albumin | 1 | 2016 | 673 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2016 | 245 | 0.100 |
Why?
|
Firearms | 1 | 2020 | 626 | 0.100 |
Why?
|
Sutures | 1 | 1994 | 282 | 0.100 |
Why?
|
Medicine | 1 | 2021 | 942 | 0.100 |
Why?
|
Trauma Centers | 1 | 2017 | 936 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2019 | 631 | 0.100 |
Why?
|
History, 15th Century | 1 | 2011 | 29 | 0.100 |
Why?
|
Pelvic Inflammatory Disease | 1 | 1992 | 96 | 0.100 |
Why?
|
Medically Uninsured | 1 | 2017 | 835 | 0.100 |
Why?
|
History, Medieval | 1 | 2011 | 62 | 0.100 |
Why?
|
Population | 1 | 2012 | 141 | 0.100 |
Why?
|
History, 16th Century | 1 | 2011 | 70 | 0.100 |
Why?
|
History, 17th Century | 1 | 2011 | 108 | 0.090 |
Why?
|
Radiosurgery | 1 | 2021 | 1339 | 0.090 |
Why?
|
Prosthesis Design | 4 | 2012 | 2114 | 0.090 |
Why?
|
Remote Consultation | 1 | 2014 | 237 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2014 | 915 | 0.090 |
Why?
|
Arteries | 1 | 2016 | 1120 | 0.090 |
Why?
|
Occupational Diseases | 1 | 1999 | 1490 | 0.090 |
Why?
|
History, Ancient | 1 | 2011 | 212 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2671 | 0.090 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8516 | 0.090 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6403 | 0.090 |
Why?
|
Cadaver | 3 | 2011 | 1358 | 0.090 |
Why?
|
Health Personnel | 1 | 2024 | 3333 | 0.090 |
Why?
|
Algorithms | 6 | 2023 | 14024 | 0.090 |
Why?
|
Multiple Myeloma | 2 | 2019 | 5144 | 0.090 |
Why?
|
Equipment Safety | 2 | 2008 | 249 | 0.090 |
Why?
|
Chlamydia trachomatis | 1 | 1992 | 239 | 0.090 |
Why?
|
Mental Health | 2 | 2022 | 3253 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1997 | 943 | 0.090 |
Why?
|
Hepatitis | 1 | 1992 | 228 | 0.090 |
Why?
|
Shoulder Joint | 2 | 2014 | 742 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2019 | 1795 | 0.090 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2724 | 0.090 |
Why?
|
Peritonitis | 1 | 1992 | 368 | 0.090 |
Why?
|
Motor Vehicles | 1 | 2011 | 282 | 0.080 |
Why?
|
Hyperbaric Oxygenation | 1 | 2011 | 165 | 0.080 |
Why?
|
Regression Analysis | 3 | 2016 | 6339 | 0.080 |
Why?
|
Clinical Competence | 4 | 2013 | 4790 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2585 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2023 | 3743 | 0.080 |
Why?
|
Ligaments | 1 | 2010 | 127 | 0.080 |
Why?
|
Terminal Care | 1 | 2021 | 1755 | 0.080 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 313 | 0.080 |
Why?
|
Causality | 1 | 2015 | 1241 | 0.080 |
Why?
|
Device Approval | 1 | 2011 | 163 | 0.080 |
Why?
|
Autopsy | 1 | 2013 | 1008 | 0.080 |
Why?
|
Genetic Markers | 1 | 2015 | 2601 | 0.080 |
Why?
|
Ultrasonography | 4 | 1999 | 5965 | 0.080 |
Why?
|
Prevalence | 3 | 2014 | 15702 | 0.080 |
Why?
|
Fibrocartilage | 1 | 2009 | 17 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2164 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6305 | 0.080 |
Why?
|
Patient Satisfaction | 3 | 2022 | 3451 | 0.080 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 2073 | 0.080 |
Why?
|
Consensus | 3 | 2023 | 3117 | 0.080 |
Why?
|
Chlamydia Infections | 1 | 1992 | 365 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6807 | 0.080 |
Why?
|
Peer Review, Research | 1 | 2012 | 339 | 0.080 |
Why?
|
Computer Simulation | 2 | 2012 | 6233 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1800 | 0.080 |
Why?
|
Demography | 1 | 2013 | 1643 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2022 | 4810 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14649 | 0.070 |
Why?
|
Unconsciousness | 1 | 2010 | 249 | 0.070 |
Why?
|
Random Allocation | 2 | 2011 | 2392 | 0.070 |
Why?
|
Histocytochemistry | 1 | 2009 | 696 | 0.070 |
Why?
|
Cell Shape | 1 | 2009 | 369 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2419 | 0.070 |
Why?
|
Canada | 1 | 2013 | 2120 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3634 | 0.070 |
Why?
|
Polyglycolic Acid | 1 | 2009 | 406 | 0.070 |
Why?
|
Bone and Bones | 2 | 2010 | 2565 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2010 | 957 | 0.070 |
Why?
|
Child | 7 | 2024 | 80089 | 0.070 |
Why?
|
Infant, Newborn | 6 | 2022 | 26183 | 0.070 |
Why?
|
Chondrogenesis | 1 | 2009 | 238 | 0.070 |
Why?
|
Tendon Injuries | 1 | 2011 | 328 | 0.070 |
Why?
|
Russia | 1 | 2008 | 382 | 0.070 |
Why?
|
Infant | 4 | 2023 | 36157 | 0.070 |
Why?
|
Knee Joint | 1 | 2015 | 1676 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3611 | 0.070 |
Why?
|
Bone Marrow | 1 | 1997 | 2909 | 0.070 |
Why?
|
Polymethyl Methacrylate | 1 | 2007 | 132 | 0.070 |
Why?
|
Motorcycles | 1 | 2007 | 42 | 0.070 |
Why?
|
Bone Diseases | 1 | 2010 | 418 | 0.070 |
Why?
|
Posture | 2 | 2022 | 956 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4573 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 1784 | 0.070 |
Why?
|
Insurance Claim Review | 2 | 2021 | 741 | 0.070 |
Why?
|
Anticoagulants | 2 | 2019 | 4785 | 0.070 |
Why?
|
Freezing | 1 | 2007 | 311 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 2 | 2024 | 1002 | 0.070 |
Why?
|
Femur Head | 1 | 2008 | 297 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2689 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1700 | 0.060 |
Why?
|
Neoplasms | 3 | 2024 | 22131 | 0.060 |
Why?
|
Bone Cements | 1 | 2007 | 325 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.060 |
Why?
|
Child, Preschool | 4 | 2023 | 42193 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6223 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3164 | 0.060 |
Why?
|
Arthroplasty | 1 | 2008 | 310 | 0.060 |
Why?
|
Tensile Strength | 3 | 2012 | 330 | 0.060 |
Why?
|
Pediatrics | 1 | 2020 | 3589 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2756 | 0.060 |
Why?
|
STAT3 Transcription Factor | 1 | 2009 | 871 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4237 | 0.060 |
Why?
|
Radiation Dosage | 2 | 2024 | 1956 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5911 | 0.060 |
Why?
|
Device Removal | 1 | 2010 | 629 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2012 | 1173 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 10203 | 0.060 |
Why?
|
Disasters | 1 | 2011 | 520 | 0.060 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4309 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3245 | 0.060 |
Why?
|
Range of Motion, Articular | 1 | 2011 | 1587 | 0.060 |
Why?
|
Hydrocodone | 1 | 2024 | 48 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3901 | 0.060 |
Why?
|
Chest Pain | 2 | 2021 | 1091 | 0.060 |
Why?
|
Menstruation | 1 | 1986 | 306 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2011 | 1528 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4252 | 0.060 |
Why?
|
Checklist | 1 | 2010 | 827 | 0.060 |
Why?
|
Boston | 2 | 2017 | 9313 | 0.050 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2024 | 343 | 0.050 |
Why?
|
Oxycodone | 1 | 2024 | 139 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5672 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1661 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Emergencies | 2 | 2019 | 1217 | 0.050 |
Why?
|
Decompression | 1 | 2022 | 36 | 0.050 |
Why?
|
Mice, Nude | 1 | 2009 | 3606 | 0.050 |
Why?
|
Hysterectomy | 2 | 1999 | 856 | 0.050 |
Why?
|
Pneumothorax | 1 | 1986 | 386 | 0.050 |
Why?
|
Hip Prosthesis | 1 | 2008 | 921 | 0.050 |
Why?
|
Capacity Building | 1 | 2024 | 259 | 0.050 |
Why?
|
Spinal Nerve Roots | 1 | 2022 | 121 | 0.050 |
Why?
|
Injections, Epidural | 1 | 2023 | 201 | 0.050 |
Why?
|
Critical Care | 1 | 2014 | 2691 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2007 | 816 | 0.050 |
Why?
|
Salvage Therapy | 1 | 2008 | 1263 | 0.050 |
Why?
|
Politics | 1 | 2008 | 813 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.040 |
Why?
|
Accounts Payable and Receivable | 1 | 2020 | 11 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11118 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2382 | 0.040 |
Why?
|
Collagen | 1 | 2009 | 2634 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2024 | 767 | 0.040 |
Why?
|
Private Sector | 1 | 2023 | 394 | 0.040 |
Why?
|
Rural Population | 2 | 2022 | 2277 | 0.040 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2024 | 549 | 0.040 |
Why?
|
Rehabilitation Centers | 1 | 2021 | 246 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12966 | 0.040 |
Why?
|
Wound Healing | 1 | 2011 | 2802 | 0.040 |
Why?
|
Intraoperative Complications | 2 | 2019 | 1161 | 0.040 |
Why?
|
Oxygen | 1 | 2011 | 4226 | 0.040 |
Why?
|
Ritodrine | 1 | 1978 | 4 | 0.040 |
Why?
|
Gelatin | 1 | 2020 | 220 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 30015 | 0.040 |
Why?
|
Colic | 1 | 1998 | 44 | 0.040 |
Why?
|
Fetal Distress | 1 | 1978 | 39 | 0.040 |
Why?
|
Health Facilities | 1 | 2024 | 578 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.040 |
Why?
|
Ascitic Fluid | 1 | 1999 | 189 | 0.040 |
Why?
|
Recurrence | 2 | 2010 | 8426 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2007 | 4802 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1096 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12942 | 0.040 |
Why?
|
Federal Government | 1 | 2020 | 267 | 0.040 |
Why?
|
Thrombin | 1 | 2020 | 592 | 0.040 |
Why?
|
Propanolamines | 1 | 1978 | 163 | 0.040 |
Why?
|
Graft Survival | 1 | 2009 | 3814 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2019 | 448 | 0.040 |
Why?
|
Marital Status | 1 | 2019 | 425 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 928 | 0.040 |
Why?
|
Hospitals, Rural | 1 | 2019 | 176 | 0.040 |
Why?
|
Financing, Personal | 1 | 2020 | 308 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2019 | 500 | 0.040 |
Why?
|
Certification | 1 | 2021 | 418 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2019 | 344 | 0.040 |
Why?
|
Urography | 1 | 1998 | 316 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2024 | 1505 | 0.040 |
Why?
|
Subacute Care | 1 | 2019 | 179 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2024 | 2690 | 0.030 |
Why?
|
Aftercare | 1 | 2023 | 913 | 0.030 |
Why?
|
Platelet Adhesiveness | 1 | 1996 | 154 | 0.030 |
Why?
|
Primary Health Care | 2 | 2024 | 4677 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2021 | 463 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9310 | 0.030 |
Why?
|
Anesthesia, Obstetrical | 1 | 1978 | 232 | 0.030 |
Why?
|
Phlebotomy | 1 | 1996 | 137 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2703 | 0.030 |
Why?
|
Risk | 2 | 2023 | 9603 | 0.030 |
Why?
|
Burnout, Professional | 1 | 2024 | 703 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Biopsy | 1 | 2007 | 6763 | 0.030 |
Why?
|
Cysts | 1 | 2021 | 680 | 0.030 |
Why?
|
Hospitals, Public | 1 | 2016 | 201 | 0.030 |
Why?
|
Educational Measurement | 2 | 2012 | 1252 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1614 | 0.030 |
Why?
|
Drainage | 1 | 2020 | 1156 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2019 | 463 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 550 | 0.030 |
Why?
|
Colectomy | 1 | 2019 | 686 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 3239 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1745 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 851 | 0.030 |
Why?
|
X-Ray Diffraction | 1 | 1994 | 421 | 0.030 |
Why?
|
Ovariectomy | 1 | 1996 | 613 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8532 | 0.030 |
Why?
|
Observer Variation | 2 | 2010 | 2607 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17878 | 0.030 |
Why?
|
Gynecology | 1 | 1999 | 526 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9277 | 0.030 |
Why?
|
Hematocrit | 1 | 2015 | 623 | 0.030 |
Why?
|
Platelet Aggregation | 1 | 1996 | 771 | 0.030 |
Why?
|
Connexins | 1 | 1995 | 352 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2009 | 18937 | 0.030 |
Why?
|
Headache | 1 | 2021 | 1255 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10429 | 0.030 |
Why?
|
Syndrome | 2 | 1992 | 3268 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1937 | 0.030 |
Why?
|
Pregnancy | 7 | 2022 | 29869 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1994 | 944 | 0.030 |
Why?
|
Obstetrics | 1 | 1999 | 666 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2252 | 0.020 |
Why?
|
Premenopause | 1 | 1996 | 1038 | 0.020 |
Why?
|
Explosions | 1 | 2012 | 107 | 0.020 |
Why?
|
Multigene Family | 1 | 1995 | 1076 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2034 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2009 | 11512 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2012 | 211 | 0.020 |
Why?
|
Internet | 1 | 2023 | 3094 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2925 | 0.020 |
Why?
|
Phenotype | 1 | 2009 | 16572 | 0.020 |
Why?
|
Shoulder | 1 | 2012 | 300 | 0.020 |
Why?
|
Radiotherapy | 1 | 2017 | 1497 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 6074 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11069 | 0.020 |
Why?
|
Xanthenes | 1 | 2009 | 71 | 0.020 |
Why?
|
Terrorism | 1 | 2012 | 210 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3851 | 0.020 |
Why?
|
Protective Devices | 1 | 2010 | 72 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 1994 | 532 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 568 | 0.020 |
Why?
|
Estrogens | 1 | 1996 | 1521 | 0.020 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1989 | 41 | 0.020 |
Why?
|
Stainless Steel | 1 | 2009 | 79 | 0.020 |
Why?
|
Immobilization | 1 | 2010 | 229 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2575 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 2 | 1991 | 589 | 0.020 |
Why?
|
Motion | 1 | 2012 | 779 | 0.020 |
Why?
|
Torque | 1 | 2008 | 132 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2009 | 550 | 0.020 |
Why?
|
Kidney Diseases | 1 | 1998 | 2090 | 0.020 |
Why?
|
Abruptio Placentae | 1 | 1989 | 118 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 763 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2011 | 601 | 0.020 |
Why?
|
Postmenopause | 1 | 1996 | 2511 | 0.020 |
Why?
|
Animals | 4 | 2022 | 168202 | 0.020 |
Why?
|
Tendons | 1 | 2011 | 558 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5822 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2009 | 6126 | 0.020 |
Why?
|
Friction | 1 | 2006 | 59 | 0.020 |
Why?
|
Titanium | 1 | 2009 | 485 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 591 | 0.020 |
Why?
|
Veterans | 1 | 2019 | 2649 | 0.020 |
Why?
|
Ovulation | 1 | 1986 | 181 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2467 | 0.020 |
Why?
|
Lipids | 1 | 1996 | 3332 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5789 | 0.020 |
Why?
|
Models, Statistical | 1 | 2019 | 5074 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2012 | 1882 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2008 | 683 | 0.010 |
Why?
|
Elasticity | 1 | 2006 | 655 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 247 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5780 | 0.010 |
Why?
|
Cisplatin | 1 | 2009 | 1650 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9054 | 0.010 |
Why?
|
Doxorubicin | 1 | 2009 | 2224 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1994 | 2149 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1997 | 12759 | 0.010 |
Why?
|
Diabetes, Gestational | 1 | 1991 | 1250 | 0.010 |
Why?
|
Mice | 1 | 2009 | 81368 | 0.010 |
Why?
|
Accidental Falls | 1 | 2009 | 1067 | 0.010 |
Why?
|
Edema | 1 | 1985 | 765 | 0.010 |
Why?
|
Pleural Neoplasms | 1 | 1986 | 609 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1997 | 9171 | 0.010 |
Why?
|
Transcription Factors | 1 | 2019 | 12116 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8165 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1985 | 913 | 0.010 |
Why?
|
Liver | 1 | 1995 | 7512 | 0.010 |
Why?
|
Rats | 2 | 2011 | 23716 | 0.010 |
Why?
|
Endometriosis | 1 | 1986 | 857 | 0.010 |
Why?
|
Coagulants | 1 | 1996 | 45 | 0.010 |
Why?
|
Citric Acid | 1 | 1996 | 123 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 1996 | 422 | 0.010 |
Why?
|
Genital Diseases, Female | 1 | 1996 | 192 | 0.010 |
Why?
|
Surface Properties | 1 | 1996 | 1162 | 0.010 |
Why?
|
Methylation | 1 | 1995 | 1077 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1986 | 2948 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1692 | 0.010 |
Why?
|
Fetal Macrosomia | 1 | 1991 | 141 | 0.010 |
Why?
|
DNA Primers | 1 | 1995 | 2817 | 0.010 |
Why?
|
Organ Specificity | 1 | 1995 | 1964 | 0.010 |
Why?
|
Israel | 1 | 1991 | 716 | 0.010 |
Why?
|
gamma-Globulins | 1 | 1989 | 119 | 0.010 |
Why?
|
Exons | 1 | 1995 | 2381 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11735 | 0.000 |
Why?
|
Glucose Tolerance Test | 1 | 1991 | 1178 | 0.000 |
Why?
|
Cell Membrane | 1 | 1996 | 3680 | 0.000 |
Why?
|
Transfection | 1 | 1995 | 5765 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1995 | 4110 | 0.000 |
Why?
|
Prediabetic State | 1 | 1991 | 545 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6520 | 0.000 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1985 | 116 | 0.000 |
Why?
|
Prednisone | 1 | 1989 | 1562 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12420 | 0.000 |
Why?
|
Calcium | 1 | 1996 | 5717 | 0.000 |
Why?
|
Heart Block | 1 | 1985 | 384 | 0.000 |
Why?
|
Bradycardia | 1 | 1985 | 299 | 0.000 |
Why?
|
Tachycardia | 1 | 1985 | 597 | 0.000 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1995 | 2292 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17630 | 0.000 |
Why?
|
Gene Expression | 1 | 1995 | 7569 | 0.000 |
Why?
|
DNA | 1 | 1995 | 7196 | 0.000 |
Why?
|
Cell Line | 1 | 1995 | 15577 | 0.000 |
Why?
|
Electrocardiography | 1 | 1985 | 6346 | 0.000 |
Why?
|